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ABSTRACT   1 
Background Children born preterm or with a small-size-for-gestational-age are at increased 2 
risk for childhood asthma. We tested the hypothesis that these associations are explained by 3 
reduced airway patency. 4 
Methods and Materials We used individual participant data of 24,938 children from 24 birth 5 
cohorts to examine the associations of gestational age, size-for-gestational-age, and infant 6 
weight gain with childhood lung function (forced expiratory volume in 1 second (FEV1), 7 
FEV1/forced vital capacity (FEV1/FVC), forced expiratory flow after exhaling 75% of the vital 8 
capacity (FEF75)) and risk of doctor-diagnosed asthma (age range 3.9 – 19.1 years). 9 
Second, we used similar models to explore whether these lung function outcomes mediated 10 
the associations of early growth characteristics with the risk of childhood asthma. 11 
Results Children born with a younger gestational age had a lower FEV1, FEV1/FVC, and 12 
FEF75, whereas those born with a smaller size-for-gestational-age at birth had lower FEV1 13 
but higher FEV1/FVC (p-values<0.05). Greater infant weight gain was associated with higher 14 
FEV1, but lower FEV1/FVC and FEF75 in childhood (p-values<0.05). All associations were 15 
present across the full ranges and independent  of other early life growth characteristics. In 16 
line with these observations, preterm birth, low birth weight and greater infant weight gain 17 
were associated with an increased risk of childhood asthma (pooled odds ratio (95% CI): 18 
1.50 (1.2, 1.57), 1.40 (1.18, 1.65) and 1.23 (1.17, 1.28), respectively). These associations 19 
were mediated up to 45% by lung function characteristics.Mediation analyses suggested that 20 
FEV1, FEV1/FVC and FEF75 may explain 6.3 (2.5, 9.9)% to 44.6 (14.6, 81.1)% of the 21 
associations between early growth characteristics and lung function. 22 
Conclusions Results from this individual participant meta-analysis suggest that younger 23 
gestational age at birth, smaller size-for-gestational-age at birth, and greater infant weight 24 
gain across the full ranges were associated with adaptations in childhood lung function, and 25 
that these associations explain to a substantial extent the risk of childhood asthma.  26 
 27 
 28 
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INTRODUCTION 29 
Children born extremely preterm or with a low birth weight have high rates of neonatal 30 
respiratory diseases such as infant respiratory distress syndrome and bronchopulmonary 31 
dysplasia (1). An accumulating body of evidence suggests that these children also have an 32 
increased risk of chronic obstructive respiratory diseases in adulthood (2). More recent, 33 
prospective studies in children suggest that preterm birth and small size for gestational age 34 
at birth increase the risk of childhood asthma (3). Recent results of a meta-analysis of 35 
individual participant data of 147,000 children participating in prospective birth cohort studies 36 
showed consistent associations of younger gestational age at birth and greater infant weight 37 
gain with childhood asthma (4). The associations of lower birth weight with childhood asthma 38 
seem to be largely explained by gestational age at birth (4). The mechanisms underlying the 39 
associations of early growth characteristics with childhood asthma are not known yet. Airway 40 
caliber is a key determinant of total airway resistance. A reduced airway caliber could result 41 
in airway obstruction that predisposes to asthma and chronic obstructive pulmonary 42 
diseases (5-7). Therefore, we hypothesized that the associations of early growth 43 
characteristics with childhood asthma might be explained by , but might include 44 
developmental adaptations of the lungs and airways, leading to relatively small airways and, 45 
hence, a reduction in expiratory flows reflected by lower lung function values (8). Thus far, 46 
previous studies focused on the associations of birth weight and infant weight gain with 47 
childhood lung function have reported inconsistent results (9-16). These inconsistent results 48 
might be due to the different ages at which spirometry was performed, and not taking other 49 
early growth characteristics or potential confounders into account. 50 
 To test the hypothesis that the associations of early life growth characteristics with 51 
childhood asthma are explained by reduced airway patency, we performed an individual 52 
participant data meta-analysis of 24,938 children from 24 birth cohort studies. We examined 53 
the strength, consistency, and independence of the associations of gestational age at birth, 54 
birth weight and infant weight gain with lung function outcomes in childhood and whether 55 
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these lung function outcomes explain the previously reported associations of early growth 56 
characteristics with risk of childhood asthma.  57 
 58 
METHODS  59 
 60 
Sources of data 61 
European population-based birth- and mother-child cohorts participated if they included 62 
children born between 1989 and 2011, had information available on at least gestational age 63 
and weight at birth and lung function measurements in childhood (until age 18 years), and 64 
were willing and able to exchange original data.(4) We identified 52 European cohorts 65 
selected from existing collaborations on childhood health or asthma-related outcomes 66 
(www.chicosproject.eu, www.birthcohortsenrieco.net, www.ga2len.org, 67 
and www.birthcohorts.net; assessed until May 29, 2012). In total, 24 cohorts, comprising 68 
data on 24,938 children, fulfilled the criteria (Supporting Information: S-figure 1). 69 
 Information about gestational age and weight at birth and weight in the first year of 70 
life was obtained by measurements, medical registries or parental questionnaires 71 
(Supporting Information: S-table 1). We created gestational age-adjusted birth weight 72 
standard deviation scores (birth weight SDS) based on European reference values (17). 73 
Infant weight gain in the first year was defined as the difference between weight at age 1 74 
year (range 6-18 months) and weight at birth, divided by the number of months between 75 
these two measurements. Standard deviation scores (SDS) for age-specific infant weight 76 
gain were derived by intra-cohort means and standard deviations (18). Cohort specific 77 
growth characteristics are given in the Supporting Information (S-table 2). 78 
All cohorts obtained lung function measurements by spirometry, most of them (n = 79 
21)of which 22 according to the recent guidelines of the American Thoracic Society / 80 
European Respiratory Society (ATS/ERS) (19-21), and 2 according to earlier guidelines of 81 
the ATS (22) or ERS and European Coal and Steel Community (23) (Supporting 82 
Information: S-table 1) (21-23). If cohorts had collected lung function data at multiple time 83 
Field Code Changed
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points (n = 6 cohorts), we used the measurement closest to the mean age of children (8.5 84 
years) in the full meta-analysis. Variables for analyses were forced vital capacity (FVC), 85 
forced expiratory volume in 1 second (FEV1), forced mid-expiratory flow (FEF25–75) and 86 
forced expiratory flow after exhaling 75% of the vital capacity (FEF75). We mainly focused on 87 
FEV1, FEV1/FVC, and FEF75, which reflect reduced airway patency in obstructive lung 88 
diseases such as asthma or bronchopulmonary dysplasia due to preterm birth or low birth 89 
weight (24, 25). All lung function variables were converted into sex-, height-, age-, and 90 
ethnicity (Caucasian versus non-Caucasian) -adjusted Z-scores based on the Global Lung 91 
Initiative reference values (26).  Asthma (yes / no) was defined as ever physician diagnosed 92 
asthma, and was obtained by medical registries (2 cohorts) or parental questionnaires 93 
adapted from the International Study on Asthma and Allergy in Childhood (ISAAC) (27) (22 94 
cohorts)  at the age of spirometry (S-table1). Cohort specific characteristics of lung function 95 
measurements and asthma are given in the Supporting Information (S-table 3).  96 
We included covariates based on known associations with childhood lung function 97 
from previous studies (28, 29). Information on covariates was mainly assessed by 98 
questionnaires (Supporting Information: S-table 1). Potential confounders included 99 
maternal educational level, smoking during pregnancy, smoking during infancy of their 100 
offspring, history of asthma or atopy, child’s sex, siblings, day care attendance in the first 2 101 
years of life, breastfeeding, lower respiratory tract infections in the first 2 years of life, 102 
eczema, inhalant allergies, and body mass index (BMI) at the moment of lung function 103 
measurement. Cohort specific characteristics of all covariates are given in the Supporting 104 
Information (S-tables 4-5). 105 
 106 
Statistical analysis  107 
First, we conducted 1-stage random effect regression analyses to study the separate and 108 
combined associations of gestational age, birth weight and infant weight gain with FEV1, 109 
FVC, FEV1/FVC, FEF25-75 and FEF75. For these analyses, individual participant data from all 110 
cohorts were combined and modeled simultaneously taking into account clustering of 111 
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participants within studies (30). To prevent multicollinearity in our regression models, we 112 
started to assess the associations of gestational age and birth weight with lung function 113 
separately. Thereafter, we assessed whether the associations of birth weight with lung 114 
function was driven by gestational age by creating gestational age adjusted birth weight 115 
standard deviation scores. The models focused on the associations of infant weight gain 116 
with lung function outcomes were adjusted for gestational age and weight at birth. To test 117 
non-linear and dose-response associations, we categorized gestational age, birth weight 118 
SDS and infant weight gain SDS. As a sensitivity analysis, we conducted a 2-stage random 119 
effect meta-analysis to study the associations of gestational age, birth weight, and infant 120 
weight gain, and dichotomized preterm birth and low birth weight with each lung function 121 
outcome. For this analysis, we used linear regression models per cohort, after which pooled 122 
regression coefficients (β’s) from the per cohort effect estimates were calculated. We tested 123 
for heterogeneity between effect estimates using I2 (31, 32). For all analyses, the first model 124 
was adjusted for child’s sex (crude model), the second model was additionally adjusted for 125 
potential confounders (full model). To determine interactive effects between gestational age, 126 
birth weight and infant weight gain we added these terms multiplicative in the full model. 127 
Since we used Northern-European reference curves for birth weight SDS, we performed a 128 
sensitivity analysis to explore whether the associations were different in North-Western 129 
European subjects only. Numbers were too small to perform these analyses separately in 130 
other European regions. To assess differences in results related to pubertal growth changes, 131 
we repeated our analyses is strata of children aged < 11 years and ≥11 years (33). We also 132 
performed a complete-case sensitivity analysis to explore any differences between complete 133 
and non-complete-case analyses, and sensitivity analyses in which we excluded cohorts that 134 
used parental report of early growth characteristics or that did not perform spirometry 135 
measurements according to the ATS/ERS guidelines. 136 
Second, we conducted a 1-stage random effect regression analysis to assess the 137 
associations of early growth characteristics with asthma, and observed whether changes in 138 
the effect estimates occurred after additional adjustment for lung function measures (FEV1, 139 
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FVC, FEV1/FVC, FEF25-75 and FEF75 ) as potential mediators (mediator model). The 140 
difference between the original effect estimates and the effect estimates after additional 141 
adjustment for potential mediators was expressed as percentage change. The percentage 142 
change of the effect estimate was calculated by the formula: 100 x (effect estimatemediator - 143 
effect estimatemodel 1original model)/( effect estimatemodel 1 original model- 1). A 95% confidence interval 144 
for the percentage change of the effect estimate was calculated using a bootstrap method 145 
with 1,000 resamplings (34-36).  146 
For all analyses, missing values in covariates were used as an additional group in 147 
the categorical variables to prevent exclusion of non-complete cases. Statistical analyses 148 
were performed with R version 3.0.0 (libraries rmeta and metafor; The R foundation for 149 
Statistical Computing), and Comprehensive Meta-Analysis (Biostat, US).  150 
 151 
RESULTS  152 
 153 
Subject characteristics  154 
Information about the main characteristics of the cohorts are given in Table 1. Detailed 155 
information about determinants, outcomes and covariates is given in the Supporting 156 
Information (S-tables 1-5). Of all participants, 8.2% (n = 2,053) was born preterm (<37 157 
weeks of gestational age), and 4.8% (n = 1,191) was born with a low birth weight (<2,500 158 
gram). The mean age at which spirometry assessments were performed was 8.5 (range 3.9 159 
- 19.1) years. The proportion of children aged ≥11 years was 11.9% (n = 2,972). 160 
 161 
Early growth measures and lung function outcomes 162 
Results from the 1-stage random effect models showed that younger gestational age at birth 163 
was, across the full range, associated with lower FEV1, FEV1/FVC and FEF75 in childhood 164 
(p-values for trend <0.01) (Figures 1A-C). A smaller size-for-gestational-age at birth across 165 
the full range was associated with lower FEV1 and higher FEV1/FVC (p-values for trend 166 
<0.01) (Figures 1D-E). Small size-for-gestational-age at birth was not associated with FEF75 167 
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(Figure 1F). Greater infant weight gain was associated with a higher FEV1, but with a lower 168 
FEV1/FVC and FEF75 (p-values for trend <0.01; Figures 1G-I). Most associations showed a 169 
linear trend, except for the associations of birth weight with FEV1/FVC and infant weight gain 170 
with FEV1 and FEV1/FVC which were non-linear (Figures 1E, G, H). 171 
 To explore the combined effects of gestational age, birth weight SDS and infant 172 
weight gain SDS, we performed tests for interaction between these early growth 173 
characteristics. These tests for interaction were only significant for gestational age and birth 174 
weight SDS in relation to lung function outcomesFEV1, FEV1/FVC, FEF25-75 and FEF75 (p-175 
values for interaction <0.01; Figure 2, S-table 9). Specifically,Stratified analyses showed 176 
that a lower birth weight was associated with lower FEV1 and FEV1/FVC among children 177 
born after ≥ 32 weeks only, whereas higher birth weight was associated with FEF75 only 178 
among term born children (p-values for strata <0.05).   179 
 No differences in results were observed when we used 2-stage random effect 180 
models of combined effect estimates (Supporting Information: S-tables 6-7). Also, the 181 
results from the sensitivity analyses showed similar results when we used cohorts with 182 
North-Western European subjects only, when we excluded cohorts that did not perform 183 
spirometry measurements according to the recent ATS/ERS guidelines, when we performed 184 
stratified analyses for children aged < 11 years or ≥ 11 years (S-table 8), or when we 185 
excluded cohorts that used parental report of early growth characteristics (data not shown). 186 
Also, the results were similar when we used cohorts with North-Western European subjects 187 
only, complete-cases, or when we excluded cohorts that used parental report of early growth 188 
characteristics (Supporting Information: S-table 8) or did not perform spirometry 189 
measurements according to the ATS/ERS guidelines (data not shown). 190 
 Figure 3 shows that compared to term born children, those born preterm had a lower 191 
FEV1, FEV1/FVC and FEF75, (pooled Z-score (95% CI): -0.20 (-0.26, -0.14), -0.15 (-0.21, -192 
0.09) and -0.19 (-0.27, -0.11), respectively). Also, compared to normal birth weight children, 193 
those with a low birth weight had lower FEV1, FEV1/FVC and FEF75 (-0.29 (-0.38, -0.21) and 194 
-0.16 (-0.25, -0.08) and -0.17 (-0.26, -0.08) respectively), independent of gestational age. 195 
11 
 
Results of associations of growth characteristics with all lung function outcomes, including 196 
FVC and FEF25-75 are given in the Supporting Information: S-tables 6-8.  197 
 198 
Early growth, lung function and asthma  199 
Preterm birth, low birth weight and greater weight gain were all associated with an increased 200 
risk of childhood asthma (OR (95% CI): 1.50 (1.2, 1.57), 1.40 (1.18, 1.65) and 1.23 (1.17, 201 
1.28), respectively. The associations of preterm birth and low birth weight attenuated after 202 
additional adjustment for FEV1, FEV1/FVC or FEF75. Mediation analyses suggested that 203 
FEV1, FEV1/FVC and FEF75 may explain 6.3 (2.5, 9.9)% to 44.6 (14.6, 81.1)%. Specifically, 204 
after additional adjustment for FEV1, FEV1/FVC or FEF75, the associations of preterm birth 205 
with asthma attenuated with -7.3 (-18.8, -0.9)%, -14.4 (-39.6, -2.8)% and -39.0 (-69.3, -206 
3.4)%, respectively. Similarly, the associations of low birth weight with asthma attenuated 207 
with -19.0 (-37.3, -11.8)%, -21.6 (-47.3, -11.4)% and -21.6 (-47.3, -11.4)%, respectively 208 
(Table 2). The strongest mediating effect was observed for FEF75 for the association 209 
between gestational age and asthma (44.6 (81.1, 14.6)%). Overall, the strongest 210 
attenuations towards non-significant were observed after adjustment for FEF75 with an up to 211 
45% reduction of the effect estimate (Table 2). A similar trendSimilar trends were was 212 
observed for greater weight gain, although the associations did not attenuate into non-213 
significant. 214 
 215 
DISCUSSION  216 
In this meta-analysis of individual participant data of 24,938 children from 24 birth cohorts, 217 
we observed that lower gestational age, smaller size at birth and greater infant weight gain 218 
were all associated with lower childhood FEV1. The positive associations of birth weight and 219 
infant weight gain with FVC were larger than of the positive associations of birth weight and 220 
infant weight gain with FEV1. This combination resulted in associations of higher birth weight 221 
and infant weight gain with lower FEV1/FVC. Also, a lower gestational age at birth was 222 
associated with a lower FEF75 in childhood, suggesting persistent reduction of small airways 223 
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patency. A greater infant weight gain was associated with lower FEF75. . Remarkably, these 224 
associations were present across the full-range of early growth and not restricted to clinically 225 
diagnosed preterm- or low birth weight children. Also, the observed associations of the early 226 
life growth characteristics with lung function outcomes were independent of each other. 227 
Stratified analyses showed that children born very preterm with a relatively low birth weight 228 
had the lowest FEV1 and FEV1/FVC. The associations of early growth characteristics with 229 
childhood asthma were partly explained by lung function adaptations.  230 
 Whereas lung growth continues until the early adulthood, the most rapid 231 
development of airways and alveoli occurs in early life (37). Developmental adaptations in 232 
fetal life and infancy due to early life adverse exposures might result in impaired lung growth 233 
with smaller airways, decreased lung volume, and subsequently to an increased risk of 234 
bronchopulmonary dysplasia, asthma or COPD (9, 14, 38). Previous studies suggest that 235 
children with asthma already have a reduced lung function in the first months of life, and that 236 
this deficit  progresses into childhood and early adulthood (39, 40). Airway caliber is a key 237 
determinant of total airway resistance and reduced caliber is a prominent feature of asthma 238 
and chronic obstructive pulmonary diseases (5-7). Lower lung function in early life is likely to 239 
lead to lower peak lung function in early adulthood, and the natural decline in FEV1 from that 240 
point onwards will be accelerated by any additional adverse exposures (41). Thus, lung 241 
function during the lifecourse seems to be programmed at least partly in early life.  242 
 Children born preterm or with a very low birth weight are at increased risk of neonatal 243 
respiratory diseases (1). We observed that children born at a younger gestational age had a 244 
lower FEV1, even after taking FVC into account, and a lower FEF75 in childhood. These 245 
associations were not only present among children born very preterm, but across the full 246 
range of gestational age at birth. Moreover, the associations of preterm birth with childhood 247 
asthma were partly explained by lung function. These findings are in line with previous 248 
studies showing persistent lung function adaptions in children and adults born preterm. A 249 
recent meta-analysis of 28 published studies showed that children born between 24 and 36 250 
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weeks had a lower FEV1 at ages 5 up to 23 years (42). These and other studies suggest that 251 
preterm birth has adverse effects on lung function, persisting into adulthood (42-44).  252 
In the present study, a lower birth weight was associated with lower FEV1 in 253 
childhood. This suggests that a lower birth weight leads to a persistent reduction of airway 254 
patency. A previous study analyzed 10 studies examining the associations of birth weight 255 
with FEV1  in adults (range 19 – 70 years) (10). The authors reported a modest positive 256 
association between FEV1 and birth weight. Two recent studies from longitudinal birth 257 
cohorts among adults reported strong positive associations of birth weight with FEV1 and 258 
FEF25-75 in young adults aged 21 and 31 years (9, 11). The effect of birth weight was 259 
independent of preterm birth in both studies. However, studies among children showed 260 
conflicting results (12, 13). We observed an association of lower birth weight with lower 261 
FEV1, independent of gestational age at birth. We previously reported that the effect of lower 262 
birth weight on asthma was largely explained by gestational age (4). Therefore, although 263 
gestational age-adjusted birth weight is associated with lower lung function this seems not 264 
related to the risk of clinically manifest childhood asthma.  265 
Previous studies examining associations between infant weight gain and childhood 266 
lung function have reported inconsistent results (14-16). Differences might be due to 267 
different ages at which spirometry was performed, not taking other weight characteristics 268 
into account, such as birth weight or current body mass index, and possible hidden bias due 269 
to the use of mL instead of Z-scores for lung function (45). In line with the findings for birth 270 
weight, we observed that lower infant weight gain was associated with a lower childhood 271 
FEV1. This association was fully explained by FVC. These results suggest dysanapsis, in 272 
which airways remained small in relation to total lung volume as a result of a mismatch 273 
between airway and alveolar growth (46).Hence, a lower FEV1  due to lower birth weight or 274 
infant weight can be explained by a lower lung volume. Greater infant weight gain was also 275 
associated with a lower FEF75, which is in line with previous studies reporting associations of 276 
body mass index or adiposity with reduced expiratory flows and asthma (47, 48). A 277 
suggested mechanism is leptin release from adipose tissue, which might have pro-278 
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inflammatory effects in the airways (49), or a direct effect of increased body weight on lung 279 
function (50). However, our analyses were adjusted for childhood body mass index. Further 280 
studies are needed to explore whether the associations of infant weight gain with end-281 
expiratory flows are explained by specific adiposity-related measures or biomarkers.  282 
To the best of our knowledge this is the first study that examines the individual and 283 
combined associations of the main early growth characteristics with childhood lung function 284 
outcomes, and whether lung function adaptations explain the previously reported 285 
associations of early growth characteristics with childhood asthma. showing associations of 286 
all early growth characteristics with lung function and subsequent risk of childhood asthma. 287 
Our results suggest that respiratory consequences of preterm birth and a low birth weight 288 
present across the full range. This observation might have important population effects, 289 
since the largest majority of children are in the less extreme ranges of gestational age and 290 
weight at birth. Furthermore, our results suggest that the associations of gestational age, 291 
birth weight and infant weight gain with childhood asthma are at least partly explained by 292 
adaptions in airway caliber. We observed strong effect estimates with wide confidence 293 
intervals. Therefore, these mediation effects should be interpreted carefully. The effect 294 
estimates for the observed associations could be considered as small and without clinical 295 
relevance for individuals. However, the associations may be important from an etiological 296 
respiratory developmental perspective and may be important on a population-level. The 297 
associations of early growth characteristics with lung function outcomes seemed already 298 
established before the pubertal growth spurt. The largest lung and airway growth occurs 299 
before pubertal growth spurt (37, 51), with FVC increasing proportionately more than the 300 
FEV1 (33). Lung and airway growth is proportionally less after start of the pubertal growth 301 
spurt (33), which might explain the similar effect estimates before and after the pubertal 302 
growth spurt. Further studies are needed to identify the developmental adaptations of the 303 
lungs and immune system that might explain the mediating effect of lung function on the 304 
associations of early growth characteristics with childhood asthma. More information is 305 
needed on the specific maternal and childhood exposures, which lead to the specific early 306 
15 
 
growth patterns and affect the risk of later life respiratory diseases. Identification of 307 
modifiable exposures may lead to development of future preventive strategies.  308 
Some methodological limitations need to be discussed. We used data from 24 309 
ongoing cohort studies. Missing values always occur in these studies. Since we did not have 310 
additional data on patterns of missing values in all 24 cohorts, we were not able to perform 311 
multiple imputation. Data on childhood asthma was mainly obtained by parental 312 
questionnaires adapted from the International Study on Asthma and Allergy in Childhood 313 
(ISAAC) (27). This questionnaire has been validated in various age groups in many 314 
countries against measurements of bronchial hyperresponsiveness and doctor-diagnosed 315 
asthma, and is widely accepted in epidemiological studies. We did not have information on 316 
use of asthma medication, which might have influenced the lung function values in asthmatic 317 
patients. This missing information on asthma medication may have influenced our effect 318 
estimates. We would expect that asthmatic children who use asthma medication would in 319 
general have had a higher lung function values in case of good adherence and inhaler 320 
technique. We used GLI reference data to convert lung function values into Z-scores. These 321 
prediction equations were based on 74,187 individuals including 31,840 individuals aged 322 
<20 years, of whom 58% were assessed before, and 42% were assessed during pubertal 323 
growth spurt (26). To date, the GLI normal values are considered the most accurate 324 
reference values for all age ranges, and have been adopted by both the ATS and ERS. For 325 
the covariates, we imputed missing values as additional category to prevent exclusion of 326 
non-complete cases. No differences in results were observed in complete case analyses. No 327 
direct clinical and laboratory information about pubertal growth was available.  Also, 328 
although we took major potential confounders into account, residual confounding may still be 329 
an issue. No information was available about e.g. exposure to environmental micro-330 
organisms or asthma severity. Exploring mediation of lung function for the association of 331 
early growth characteristics with asthma using the method proposed by Baron and Kenny 332 
might have been limited by misclassification of lung function measurements or asthma 333 
diagnosis although we aimed to reduce this issue by multi-level modelling (52). Most of the 334 
16 
 
participating studies had measured childhood lung function and asthma at the same age. 335 
Therefore, further follow-up studies with longitudinally measured detailed data on lung 336 
function and asthma or related symptoms from birth onwards are needed to disentangle the 337 
direction of causality.  338 
 In conclusion, younger gestational age, lower birth weight and lower infant weight 339 
gain were independently associated with persistent changes in childhood lung function. 340 
These associations were present across the full spectrum of these early growth 341 
characteristics. Stratified analyses showed that children born very preterm with a relatively 342 
low birth weight had the lowest FEV1 and FEV1/FVC. Our results suggest that associations 343 
of early growth with the risk of childhood asthma were partly explained by lung function 344 
adaptations. Thus, fetal and infant growth patterns may persistently affect lung function, and 345 
thereby contribute to the risk of respiratory diseases in later life.   346 
 347 
Author’s contributions 348 
HD, AS, JJ, VJ, and LD contributed to the study design, data analysis plan, data collection, 349 
data analysis, data interpretation, writing, reviewing the manuscript critically and gave 350 
consent for submission. All other authors contributed equally to study design, data analysis 351 
plan, data collection, reviewing the manuscript critically and gave consent for submission. 352 
 353 
 REFERENCES  
1. Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term 
outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 
and 2006 (the EPICure studies). BMJ. 2012;345:e7976. 
2. Brostrom EB, Akre O, Katz-Salamon M, Jaraj D, Kaijser M. Obstructive pulmonary 
disease in old age among individuals born preterm. Eur J Epidemiol. 2013 Jan;28(1):79-85. 
3. Been JV, Lugtenberg MJ, Smets E, van Schayck CP, Kramer BW, Mommers M, et 
al. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. 
PLoS Med. 2014 Jan;11(1):e1001596. 
4. Sonnenschein-van der Voort AM, Arends LR, de Jongste JC, Annesi-Maesano I, 
Arshad SH, Barros H, et al. Preterm birth, infant weight gain, and childhood asthma risk: A 
meta-analysis of 147,000 European children. J Allergy Clin Immunol. 2014 May;133(5):1317-
29. 
5. van der Gugten A, Korte K, van der Ent K, Uiterwaal C, Verheij T. Small airway 
caliber is the most important contributor of wheezing in healthy unselected newborns. Am J 
Respir Crit Care Med. 2011 Feb 15;183(4):553; author reply -4. 
6. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, et al. 
Risk factors for hospital admission for asthma from childhood to young adulthood: a 
longitudinal population study. J Allergy Clin Immunol. 2002 Aug;110(2):220-7. 
7. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary 
disease. Lancet. 2004 Aug 21-27;364(9435):709-21. 
8. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life 
conditions on adult health and disease. N Engl J Med. 2008 Jul 3;359(1):61-73. 
Formatted: Dutch (Netherlands)
Formatted: Dutch (Netherlands)
Formatted: Dutch (Netherlands)
 9. Canoy D, Pekkanen J, Elliott P, Pouta A, Laitinen J, Hartikainen AL, et al. Early 
growth and adult respiratory function in men and women followed from the fetal period to 
adulthood. Thorax. 2007 May;62(5):396-402. 
10. Lawlor DA, Ebrahim S, Davey Smith G. Association of birth weight with adult lung 
function: findings from the British Women's Heart and Health Study and a meta-analysis. 
Thorax. 2005 Oct;60(10):851-8. 
11. Suresh S, Mamun AA, O'Callaghan M, Sly PD. The impact of birth weight on peak 
lung function in young adults. Chest. 2012 Dec;142(6):1603-10. 
12. Lima Rda C, Victora CG, Menezes AM, Barros FC. Respiratory function in 
adolescence in relation to low birth weight, preterm delivery, and intrauterine growth 
restriction. Chest. 2005 Oct;128(4):2400-7. 
13. Lum S, Hoo AF, Dezateux C, Goetz I, Wade A, DeRooy L, et al. The association 
between birthweight, sex, and airway function in infants of nonsmoking mothers. Am J 
Respir Crit Care Med. 2001 Dec 1;164(11):2078-84. 
14. Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR. 
Associations between birth weight, early childhood weight gain and adult lung function. 
Thorax. 2009 Mar;64(3):228-32. 
15. Sherrill DL, Guerra S, Wright AL, Morgan WJ, Martinez FD. Relation of early 
childhood growth and wheezing phenotypes to adult lung function. Pediatr Pulmonol. 2011 
Oct;46(10):956-63. 
16. van der Gugten AC, Koopman M, Evelein AM, Verheij TJ, Uiterwaal CS, van der Ent 
CK. Rapid early weight gain is associated with wheeze and reduced lung function in 
childhood. Eur Respir J. 2012 Feb;39(2):403-10. 
17. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P. An update of 
the Swedish reference standards for weight, length and head circumference at birth for given 
gestational age (1977-1981). Acta Paediatr Scand. 1991 Aug-Sep;80(8-9):756-62. 
Formatted: Dutch (Netherlands)
 18. Bland JM, Altman DG. Measurement error. BMJ. 1996 Jun 29;312(7047):1654. 
19. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. General 
considerations for lung function testing. Eur Respir J. 2005 Jul;26(1):153-61. 
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. 
Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. 
21. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. 
Standardisation of the measurement of lung volumes. Eur Respir J. 2005 Sep;26(3):511-22. 
22. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J 
Respir Crit Care Med. 1995 Sep;152(3):1107-36. 
23. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung 
volumes and forced ventilatory flows. Report Working Party Standardization of Lung 
Function Tests, European Community for Steel and Coal. Official Statement of the European 
Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5-40. 
24. Bjermer L. The role of small airway disease in asthma. Curr Opin Pulm Med. 2014 
Jan;20(1):23-30. 
25. Lipworth B, Manoharan A, Anderson W. Unlocking the quiet zone: the small airway 
asthma phenotype. Lancet Respir Med. 2014 Jun;2(6):497-506. 
26. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic 
reference values for spirometry for the 3-95-yr age range: the global lung function 2012 
equations. Eur Respir J. 2012 Dec;40(6):1324-43. 
27. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International 
Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 
1995 Mar;8(3):483-91. 
Formatted: Dutch (Netherlands)
 28. Boezen HM, Vonk JM, van Aalderen WM, Brand PL, Gerritsen J, Schouten JP, et al. 
Perinatal predictors of respiratory symptoms and lung function at a young adult age. Eur 
Respir J. 2002 Aug;20(2):383-90. 
29. Kotecha SJ, Watkins WJ, Paranjothy S, Dunstan FD, Henderson AJ, Kotecha S. 
Effect of late preterm birth on longitudinal lung spirometry in school age children and 
adolescents. Thorax. 2012 Jan;67(1):54-61. 
30. Debray TP, Moons KG, Abo-Zaid GM, Koffijberg H, Riley RD. Individual participant 
data meta-analysis for a binary outcome: one-stage or two-stage? PloS one. 
2013;8(4):e60650. 
31. Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. 
Statistics in medicine. 1999 Feb 15;18(3):321-59. 
32. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: 
multivariate approach and meta-regression. Statistics in medicine. 2002 Feb 28;21(4):589-
624. 
33. Quanjer PH, Stanojevic S, Stocks J, Hall GL, Prasad KV, Cole TJ, et al. Changes in 
the FEV(1)/FVC ratio during childhood and adolescence: an intercontinental study. Eur 
Respir J. 2010 Dec;36(6):1391-9. 
34. Baron RM, Kenny DA. The moderator-mediator variable distinction in social 
psychological research: conceptual, strategic, and statistical considerations. J Pers Soc 
Psychol. 1986 Dec;51(6):1173-82. 
35. Cerin E, MacKinnon DP. A commentary on current practice in mediating variable 
analyses in behavioural nutrition and physical activity. Public Health Nutr. 2009 
Aug;12(8):1182-8. 
36. MacKinnon DP, Fairchild AJ. Current Directions in Mediation Analysis. Curr Dir 
Psychol Sci. 2009 Feb;18(1):16-20. 
 37. Narayanan M, Owers-Bradley J, Beardsmore CS, Mada M, Ball I, Garipov R, et al. 
Alveolarization continues during childhood and adolescence: new evidence from helium-3 
magnetic resonance. Am J Respir Crit Care Med. 2012 Jan 15;185(2):186-91. 
38. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, Shaheen SO. Relation of 
birth weight and childhood respiratory infection to adult lung function and death from chronic 
obstructive airways disease. BMJ. 1991 Sep 21;303(6804):671-5. 
39. Bisgaard H, Jensen SM, Bonnelykke K. Interaction between asthma and lung 
function growth in early life. Am J Respir Crit Care Med. 2012 Jun 1;185(11):1183-9. 
40. Haland G, Carlsen KC, Sandvik L, Devulapalli CS, Munthe-Kaas MC, Pettersen M, et 
al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med. 
2006 Oct 19;355(16):1682-9. 
41. Stocks J, Sonnappa S. Early life influences on the development of chronic 
obstructive pulmonary disease. Ther Adv Respir Dis. 2013 Jun;7(3):161-73. 
42. Kotecha SJ, Edwards MO, Watkins WJ, Henderson AJ, Paranjothy S, Dunstan FD, et 
al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax. 
2013 Aug;68(8):760-6. 
43. Narang I, Rosenthal M, Cremonesini D, Silverman M, Bush A. Longitudinal 
evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med. 2008 
Jul 1;178(1):74-80. 
44. Vollsaeter M, Roksund OD, Eide GE, Markestad T, Halvorsen T. Lung function after 
preterm birth: development from mid-childhood to adulthood. Thorax. 2013 Aug;68(8):767-
76. 
45. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax. 1988 
Apr;43(4):265-7. 
 46. ad hoc Statement Committee ATS. Mechanisms and limits of induced postnatal lung 
growth. Am J Respir Crit Care Med. 2004 Aug 1;170(3):319-43. 
47. Scholtens S, Wijga AH, Seidell JC, Brunekreef B, de Jongste JC, Gehring U, et al. 
Overweight and changes in weight status during childhood in relation to asthma symptoms 
at 8 years of age. J Allergy Clin Immunol. 2009 Jun;123(6):1312-8 e2. 
48. Rzehak P, Wijga AH, Keil T, Eller E, Bindslev-Jensen C, Smit HA, et al. Body mass 
index trajectory classes and incident asthma in childhood: results from 8 European Birth 
Cohorts--a Global Allergy and Asthma European Network initiative. J Allergy Clin Immunol. 
2013 Jun;131(6):1528-36. 
49. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol 
Metab. 2004 Jun;89(6):2548-56. 
50. Dixon AE, Holguin F, Sood A, Salome CM, Pratley RE, Beuther DA, et al. An official 
American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc. 
2010 Sep;7(5):325-35. 
51. Kotecha S. Lung growth for beginners. Paediatr Respir Rev. 2000 Dec;1(4):308-13. 
52. Cole DA, Preacher KJ. Manifest variable path analysis: potentially serious and 
misleading consequences due to uncorrected measurement error. Psychol Methods. 2014 
Jun;19(2):300-15. 
 
Formatted: Dutch (Netherlands)
Formatted: Dutch (Netherlands)
 Figure 1. Associations of gestational age, birth weight and infant weight gain with FEV1, 
FEV1/FVC ratio and FEF75. 
 
Legend:  
Values represent Z-scores differences (95% confidence interval) from multi-level random 
effect models for the associations of gestational age at birth (A, B, C), gestational age 
adjusted birth weight (birth weight SDS) (D, E, F), and infant weight gain (SDS) (G, H, I) with 
lung function outcomes, compared with reference groups. Reference groups were 40-42.9 
weeks of gestational age, 0-0.99 birth weight SDS and 0.00 – 0.99 infant weight gain (SDS) 
(largest groups), and represented by an open bullet. Lung function outcomes are forced 
expiratory volume in 1 second (FEV1), FEV1/forced vital capacity (FVC) ratio, and forced 
expiratory flow at 75% of the exhaled FVC (FEF75). Models are adjusted for maternal 
education, smoking during pregnancy, smoking during childhood, atopy, asthma and child’s 
sex, number of siblings, daycare attendance, breastfeeding, respiratory tract infections, 
childhood eczema, inhalant allergies and body mass index. Infant weight gain SDS was 
additionally adjusted for birth weight and gestational age at birth.  
 
Figure 2. Combined associations of gestational age and birth weight with FEV1, FEV1/FVC 
ratio and FEF75. 
 
Legend:  
Values are Z-score differences (95% confidence interval) from multi-level models for the 
combined associations of gestational age at birth and birth weight SDS (A, B, C) with lung 
function outcomes, compared with reference groups. Reference groups were >37 weeks of 
gestational age with  -1.00 to 0.99 birth weight SDS  (largest group), and represented by a 
bullet. Lung function outcomes are forced expiratory volume in 1 second (FEV1), 
FEV1/forced vital capacity (FVC) ratio, and forced expiratory flow at 75% of the exhaled FVC 
(FEF75). Models are adjusted for maternal education, smoking during pregnancy, smoking 
 during childhood, atopy, asthma and child’s sex, number of siblings, daycare attendance, 
breastfeeding, respiratory tract infections, childhood eczema, inhalant allergies and body 
mass index.  *P-value < 0.05. **P-value < 0.01. Given p-values reflect differences between 
birth weight SDS groups (A, B, C) within strata of gestational age using -1.00 to 0.99 birth 
weight SDS as reference group. Pint: p-values of multiplicative interaction terms. 
 
Figure 3. Forest plots of the associations between preterm birth and low birth weight with 
FEV1, FEV1/FVC ratio and FEF75.  
 
Legend: 
Values are pooled Z-score differences (95% confidence interval) from random effect meta-
analysis for the associations of preterm birth vs. term birth (A, B, C) and low birth weight vs. 
normal birth weight (D, E, F) with lung function outcomes. Lung function outcomes are 
forced expiratory volume in 1 second (FEV1), FEV1/forced vital capacity (FVC) ratio, and 
forced expiratory flow at 75% of the exhaled FVC (FEF75). Models are adjusted for maternal 
education, smoking during pregnancy, smoking during childhood, atopy, asthma and child’s 
sex, number of siblings, daycare attendance, breastfeeding, respiratory tract infections, 
childhood eczema, inhalant allergies and body mass index. Low birth weight was adjusted 
for gestational age.  
 Table 1. Characteristics of participating cohorts. 
 
Cohort name 
(country) 
N 
Birth 
years 
Gestational 
age at birth 
(weeks) 
Birth 
weight 
(gram) 
FVC FEV1 
FEV1/ 
FVC 
FEF25-75 FEF75 
Childhood 
asthma 
 
 
 
Median 
(5-95% 
range) 
Mean (SD) Mean 
Z-score 
(SD) 
Mean 
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean 
Z-score 
(SD) 
Mean 
Z-score 
(SD) 
Yes 
ALSPAC  
(United Kingdom) 
6,873 
1991-
1992 
39.5 (1.9) 3,424 (543) 
0.49  
(1.28) 
0.44 
(1.17) 
-0.07 
(1.15) 
0.04 
(1.08) 
0.30 
(1.06) 
17.9 
(1,231) 
BAMSE 
(Sweden 
2,042 
1994-
1996  
39.9 (1.8) 3,537 (551)  
0.65 
(0.93) 
0.45 
(0.96) 
-0.37 
(0.89) 
- - 
14.8  
(303) 
BILD  
(Switzerland) 
159 
1999-
ongoing 
39.7 (1.3) 3,367 (441) 
-0.23  
(0.98) 
0.02 
(0.89) 
0.33 
(0.95) 
-0.06 
(0.87) 
- - 
CONER  
(Italy) 
217 
2004-
2005 
39.2 (1.4) 3,335 (457) 
-1.76 
(0.82) 
-1.04 
(0.90) 
0.51 
(1.65) 
0.45 
(1.00) 
- 
6.0  
(13) 
COPSAC2000  
(Denmark) 
314 
1998-
2001 
40.0 (1.6) 3,529 (531) 
-0.53 
(0.98) 
-0.11 
(1.03) 
0.47 
(0.95) 
- - 
18.8  
(59) 
EDEN  
(France) 
897 
2003-
2005 
39.3 (1.7) 3,284 (514) 
-1.08 
(1.05) 
-0.77 
(1.03) 
0.21 
(0.97) 
-0.39 
(1.01) 
0.16 
(0.88) 
18.1  
(162) 
GASPII  
(Italy) 
453 
2003-
2004 
39.2 (1.8) 3,314 (530) 
0.06 
(0.76) 
-0.01 
(0.88) 
-0.15 
(0.97) 
-0.30 
(0.90) 
- 
6.6 
(30) 
GENERATION R  
(The Netherlands) 
1,927 
2002-
2006 
39.7 (1.9) 3,392 (576) 
0.23 
(0.92) 
0.15 
(0.95) 
-0.19 
(0.92) 
0.15 
(1.05) 
-0.09 
(0.89) 
5.5  
(106) 
GENERATION XXI  
(Portugal) 
1,562 
2005-
2006 
38.4 (2.1) 3,152 (551) 
0.41 
(0.95) 
0.59 
(0.98) 
0.21 
(0.82) 
0.12 
(0.85) 
0.44 
(0.80) 
6.5  
(102) 
GINI 
(Germany) 
707 
1995-
1998 
- 3,493 (479) - 
0.02 
(0.92) 
- - - 
5.9 
(49) 
INMA Gipuzkoa 
(Spain) 
277 
2006-
2008 
39.7 (1.4) 3,284 (436) 
-0.54 
(1.16) 
-0.59 
(1.17) 
-0.05 
(0.91) 
-0.45 
(0.99) 
-0.16 
(1.00) 
5.4  
(15) 
INMA Menorca  
(Spain) 
367 
1997-
1998 
39.2 (1.8) 3,200 (493) 
0.01 
(1.13) 
-0.16 
(1.07) 
-0.24 
(1.19) 
-0.42 
(1.29) 
-0.06 
(1.32) 
4.9 
(18) 
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Cohort name 
(country) 
N 
Birth 
years 
Gestational 
age at birth 
(weeks) 
Birth 
weight 
(gram) 
FVC FEV1 
FEV1/ 
FVC 
FEF25-75 FEF75 
Childhood 
asthma 
   
Median 
(5-95% 
range) 
Mean (SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Yes 
INMA Sabadell  
(Spain) 
408 
2004-
2007 
39.8 (1.3) 3,261 (404) 
-0.47 
(1.38) 
-0.57 
(1.30) 
-0.08 
(1.03) 
-0.61 
(1.00) 
-0.25 
(1.12) 
0.7 
(3) 
INMA Valencia  
(Spain) 
455 
2003-
2005 
39.6 (1.7) 3,227 (491) 
0.30 
(1.10) 
0.30 
(1.08) 
-0.04 
(0.95) 
-0.13 
(0.91) 
-0.04 
(0.90) 
- 
ISLE OF WIGHT  
(United Kingdom) 
1,030 
1989-
1990 
39.9 (1.5) 3,411 (510) 
0.24 
(0.91) 
0.39 
(1.01) 
0.22 
(1.03) 
0.04 
(0.99) 
- 
21.5  
(221) 
KOALA  
(The 
Netherlands) 
438 
2000-
2003 
40.0 (1.2) 3,552 (467) 
0.15 
(0.94) 
-0.13 
(0.95) 
-0.55 
(0.84) 
- - 
8.0 
(35) 
LEICESTER 
1990  
(United Kingdom) 
290 
1985-
1990 
39.0 (2.2) 3,373 (599) 
-0.33 
(1.11) 
-0.38 
(1.12) 
-0.76 
(0.90) 
-0.62 
(1.01) 
- 
37.2  
(108) 
LEICESTER 
1998  
(United Kingdom) 
1,476 
1993-
1997 
39.2 (2.0) 3,314 (592) 
-0.41 
(1.04) 
-0.39 
(1.05) 
0.01 
(1.03) 
- 
0.05 
(0.94) 
36.4  
(538) 
MAS 
(Germany) 
641 1990 40.0 (1.4) 3,414 (460) 
-0.06 
(0.97) 
0.24 
(1.00) 
0.41 
(1.00) 
1.15 
(0.14) 
- 
5.0 
(32) 
PIAMA  
(The 
Netherlands) 
1,767 
1996-
1997 
39.9 (1.7) 3,526 (540) 
0.04 
(0.95) 
0.07 
(1.04) 
-0.04 
(1.01) 
-1.67 
(1.21) 
-0.21 
(0.95) 
10.0  
(176) 
RHEA  
(Greece) 
666 
2007-
2008 
38.1 (1.7) 3,175 (506) 
-0.25 
(1.09) 
-0.33 
(1.14) 
-0.10 
(0.94) 
-0.38 
(0.96) 
-0.17 
(1.05) 
5.9 
(39) 
SEATON  
(United Kingdom) 
578 1997 39.5 (1.8) 3,488 (563) 
-0.12 
(1.08) 
-0.06 
(1.08) 
-0.04 
(0.96) 
-0.27 
(0.98) 
- 
20.1  
(116) 
SWS 
(United Kingdom) 
803 
1998-
2007 
39.7 (1.9) 3,447 (548) 
0.13 
(1.01) 
0.03 
(0.95) 
-0.18 
(1.05) 
-0.28 
(0.94) 
- 
15.1  
(121) 
WHISTLER  
(The 
Netherlands) 
591 
2001-
2012 
40.0 (1.3) 3,553 (499) 
0.16 
(1.11) 
0.46 
(1.14) 
0.31 
(0.93) 
-0.04 
(1.23) 
0.12 
(1.07) 
9.3  
(55) 
 N = number of participants with information on at least gestational age or birth weight, and a lung function outcome. Lung function outcomes are forced vital 
capacity (FVC), force expiratory volume in 1 second (FEV1), mid forced expiratory flow (FEF25-75) and force expiratory flow at 75% of the exhaled FVC 
(FEF75). Values are means (standard deviations) and percentages (absolute numbers) for the information on asthma. Additional information on data collection 
(Table S1), determinants (Table S2), outcomes (Table S3), and maternal and child related covariates (Tables S4, S5)  is provided in the Supporting 
Information.
 Table 2. Associations of birth weight, gestational age and infant weight gain with childhood asthma, additionally adjusted for lung function. 
*p<0.05 **p<0.01. Values are odds ratios or percentage change in odds ratios (95% confidence interval) from random effect models and represent the risk of asthma per week, 
500 grams or SDS increase in gestational age, birth weight, gestational age adjusted birth weight (birth weight SDS), or infant weight gain (SDS), respectively, or represent 
odds ratios or percentage change in odds ratios (95% confidence interval) in risk of asthma for preterm birth vs. term birth,  low birth weight vs. normal birth weight or small for 
gestational age vs. normal and large for gestational age (<10
th
 percentile vs >10
th
 percentile). Percentage  change in odds ratio (OR) is calculated using the formula (100 x 
(ORmediator - ORmodel 1)/(ORmodel 1 - 1)), with corresponding 95% confidence interval obtained by bootstrap procedures. To enable comparison of effect estimates, results for 
gestational age adjusted birth weight and infant weight gain are presented as per SDS. Models are adjusted for maternal education, smoking during pregnancy, smoking during 
childhood, atopy, asthma and child’s sex, number of siblings, daycare attendance, breastfeeding, respiratory tract infections, childhood eczema, inhalant allergies and body 
mass index (full model), and additionally for lung function outcomes (mediator model). 
 
 
 Risk of childhood asthma 
Odds ratio (95% Confidence Interval) 
  
Full model 
Full model  
+ FEV1 
% change 
(95% CI) 
Full model  
+ FEV1/FVC 
% change 
(95% CI) 
Full model  
+ FEF75 
% change 
(95% CI) 
        
Gestational age (weeks) 0.94  
(0.92, 0.97)** 
n = 15,019 
 
0.95  
(0.93, 0.97)** 
n = 14,832 
-9.8% 
(- 16.4, - 5.3)** 
0.95  
(0.93, 0.97)** 
n = 14,017 
-13.5%  
(-21.0, -7.3)** 
0.97  
(0.94, 1.00) 
n = 9,177 
-44.6% 
(-81.1, -14.6)** 
Preterm birth (<37 weeks) 1.34  
(1.15, 1.57)** 
n = 15,019 
1.30  
(1.11, 1.53)** 
n = 14,832 
-7.3%  
(-18.8, -0.9)* 
1.27  
(1.08, 1.49)** 
n = 14,017 
-14.4% 
(-39.6, -2.8)* 
1.20  
(0.99, 1.47)  
n = 9,177 
-39.0% 
(-69.3, -3.4)* 
Birth weight (500 grams) 0.94  
(0.90, 0.97)** 
n = 15,547 
 
0.95  
(0.91, 0.99)* 
n = 15,360 
-18.9%  
(-37.0, -11.2)** 
0.94  
(0.90, 0.98)** 
n = 13,985 
-10.5%  
(-21.9, -3.4)** 
0.96  
(0.92, 1.02) 
n = 9,135 
-17.8 
(-50.6, -9.0)** 
Low birth weight (<2,500 grams) 1.32  
(1.07, 1.62)** 
n = 15,547 
 
 
1.25  
(1.02, 1.54)* 
n = 15,360 
-19.0%  
(-37.3, -11.8)** 
1.23  
(0.99, 1.52) 
n = 13,985 
-21.6%  
(-47.3, -11.4)** 
1.05  
(0.81, 1.36)  
n = 9,135 
-82.5% 
(-149, 10.3) 
Birth weight (SDS)  0.98  
(0.94, 1.03) 
n = 14,947 
1.00  
(0.96, 1.05) 
n = 14,760 
-83.8% 
(-950, 825) 
0.98  
(0.94, 1.03) 
n =13,946 
-14.0% 
(-247, 281) 
0.99  
(0.93, 1.04) 
n = 9,122 
-15.8% 
(-158, 169) 
Small for gestational age (<10th percentile) 1.18  
(1.01, 1.37)* 
n = 14,947 
 
1.13  
(0.97, 1.32) 
n = 14,760 
-28.9% 
(-253, 108) 
1.16  
(0.99, 1.36) 
n = 13,946 
-18.8% 
(-123, 164) 
1.20  
(1.00, 1.44) 
n = 9,122 
10.2% 
(-8.3, 26.2) 
Infant weight gain in first year (SDS), 
adjusted for gestational age and weight at birth 
1.27  
(1.21, 1.34)** 
n = 12,511 
 
1.28  
(1.22, 1.35)** 
n = 12,511 
6.5% 
(2.3, 9.9)**  
1.25  
(1.18, 1.31)** 
n = 11,780 
-8.4%  
(-16.1, -3.2)** 
1.13  
(1.06, 1.20)** 
n = 7,969 
-60.8 
(-115, 39.5) 
 Table 2. Associations of birth weight, gestational age and infant weight gain with childhood asthma, additionally adjusted for lung function. 
 
*p<0.05 **p<0.01. Values are odds ratios or percentage change in odds ratios (95% confidence interval) from random effect models and represent the risk of 
asthma per week, 500 grams or SDS increase in gestational age, birth weight, gestational age adjusted birth weight (birth weight SDS), or infant weight gain 
(SDS), respectively, or represent odds ratios or percentage change in odds ratios (95% confidence interval) in risk of asthma for preterm birth vs. term birth, 
low birth weight vs. normal birth weight or small for gestational age vs. normal and large for gestational age (<10
th
 percentile vs >10
th
 percentile). Percentage  
change in odds ratio (OR) is calculated using the formula (100 x (ORmediator - ORmodel 1)/(ORmodel 1 - 1)), with corresponding 95% confidence interval obtained by 
bootstrap procedures. To enable comparison of effect estimates, results for gestational age adjusted birth weight and infant weight gain are presented as per 
SDS. Models are adjusted for maternal education, smoking during pregnancy, smoking during childhood, atopy, asthma and child’s sex, number of siblings, 
 
 
 Risk of childhood asthma 
Odds ratio (95% Confidence Interval) 
  
Full model 
Full model  
+ FEV1 
% change 
(95% CI) 
Full model  
+ FEV1/FVC 
% change 
(95% CI) 
Full model  
+ FEF75 
% change 
(95% CI) 
        
Gestational age (weeks) 0.94  
(0.92, 0.97)** 
0.95  
(0.93, 0.97)** 
-9.8% 
(- 16.4, - 5.3)** 
0.95  
(0.93, 0.97)** 
-13.5%  
(-21.0, -7.3)** 
0.97  
(0.94, 1.00) 
-44.6% 
(-81.1, -14.6)** 
Preterm birth (<37 weeks) 1.34  
(1.15, 1.57)** 
1.30  
(1.11, 1.53)** 
-7.3%  
(-18.8, -0.9)* 
1.27  
(1.08, 1.49)** 
-14.4% 
(-39.6, -2.8)* 
1.20  
(0.99, 1.47) 
-39.0% 
(-69.3, -3.4)* 
Birth weight (500 grams) 0.94  
(0.90, 0.97)** 
0.95  
(0.91, 0.99)* 
-18.9%  
(-37.0, -11.2)** 
0.94  
(0.90, 0.98)** 
-10.5%  
(-21.9, -3.4)** 
0.96  
(0.92, 1.02) 
-17.8 
(-50.6, -9.0)** 
Low birth weight (<2,500 grams) 1.32  
(1.07, 1.62)** 
1.25  
(1.02, 1.54)* 
-19.0%  
(-37.3, -11.8)** 
1.23  
(0.99, 1.52) 
-21.6%  
(-47.3, -11.4)** 
1.05  
(0.81, 1.36) 
-82.5% 
(-149, 10.3) 
Birth weight (SDS)  0.98  
(0.94, 1.03) 
1.00  
(0.96, 1.05) 
-83.8% 
(-950, 825) 
0.98  
(0.94, 1.03) 
-14.0% 
(-247, 281) 
0.99  
(0.93, 1.04) 
-15.8% 
(-158, 169) 
Small for gestational age (<10th 
percentile) 
1.18  
(1.01, 1.37)* 
1.13  
(0.97, 1.32) 
-28.9% 
(-253, 108) 
1.16  
(0.99, 1.36) 
-18.8% 
(-123, 164) 
1.20  
(1.00, 1.44) 
10.2% 
(-8.3, 26.2) 
Infant weight gain in first year (SDS), 
adjusted for gestational age and weight at 
birth 
1.27  
(1.21, 1.34)** 
1.28  
(1.22, 1.35)** 
6.5% 
(2.3, 9.9)**  
1.25  
(1.18, 1.31)** 
-8.4%  
(-16.1, -3.2)** 
1.13  
(1.06, 1.20)** 
-60.8 
(-115, 39.5 
 daycare attendance, breastfeeding, respiratory tract infections, childhood eczema, inhalant allergies and body mass index (full model), and additionally for 
lung function outcomes (mediator model). 
 
